Nanoplastics During Pregnancy Disrupt the Placenta by Skewing Immune Cells Toward Inflammation

Tiny fragments of plastic have already been found in human blood, lungs, placentas, and even umbilical cord blood, but one of the most urgent questions has remained stubbornly unresolved: what do these particles actually do inside the womb? A new study published in the Journal of Nanoparticle Research offers one of the clearest answers yet. Researchers from Beijing Obstetrics and Gynecology Hospital at Capital Medical University report that polystyrene nanoplastics, among the most ubiquitous plastic particles in the environment, can impair placental function during pregnancy by derailing the delicate immune balance that keeps the organ working peacefully between mother and fetus. At the center of the story is a single gene, ARG1, whose steady decline under nanoplastic exposure appears to act as both a driver of placental damage and a reliable warning sign of toxicity.

The placenta is far more than a passive conduit for nutrients and oxygen. It is a highly regulated immunological interface, an organ that must tolerate a genetically distinct fetus while still defending both mother and child from infection. Resident macrophages, the immune cells that patrol placental tissue, are central to this balancing act. In their resting, anti-inflammatory M2 state, these cells promote immune tolerance, tissue remodeling, and healthy vascular development. When they shift into the pro-inflammatory M1 state, they mount antimicrobial responses but also unleash cytokines that can damage the very tissue they inhabit. A healthy pregnancy depends on keeping this polarity in check, and the new research shows that nanoplastic particles can tip the scales decisively toward inflammation.

To probe the risk, the team built a two-tier experimental strategy that combined animal and human models. In vivo, pregnant mice were exposed to polystyrene nanoplastics during gestation, allowing the researchers to examine placental toxicity in a living system where maternal circulation, fetal development, and immune signaling all interact. In parallel, the investigators developed an in vitro co-culture system pairing HTR8/SVneo cells, a widely used model of human extravillous trophoblasts, with macrophages derived from THP-1 human monocytic leukemia cells treated with phorbol ester to induce differentiation. This dual design let the researchers observe the consequences of exposure in intact placentas while dissecting the cellular mechanisms at single-cell-type resolution.

The first major finding emerged from RNA sequencing of placentas harvested from exposed mice. Transcriptomic analysis revealed significant enrichment of inflammatory response pathways, including the gene ontology term GO:0006954 and multiple associated KEGG signaling pathways. In plain terms, the exposed placentas looked inflamed at the level of their gene expression. Crucially, the researchers then confirmed that this inflammatory signature was accompanied by a measurable shift in macrophage polarization: the population of immune cells within placental tissue had moved toward the M1, pro-inflammatory phenotype, at the expense of the M2, anti-inflammatory state that normally predominates in a healthy pregnancy.

From the sequencing data, the team zeroed in on three differentially expressed genes linked to inflammation: ARG1, which encodes arginase 1, a hallmark enzyme of the M2 program; CCR5, a chemokine receptor involved in immune cell trafficking and inflammatory signaling; and IL1R2, a decoy receptor for the inflammatory cytokine interleukin-1. All three were carried forward for validation in the human cell system using RT-qPCR, a technique that quantifies gene expression with high sensitivity. In PMA-treated THP-1 macrophages exposed to the nanoparticles, ARG1 and CCR5 were consistently downregulated, while IL1R2 was upregulated. Immunohistochemistry on placental tissue corroborated the changes at the protein level.

Among the three candidate markers, only one behaved identically across every layer of evidence. ARG1 showed consistent downregulation at both the transcriptional level, detected independently by RNA sequencing and RT-qPCR, and the translational level, detected by immunohistochemistry. CCR5 and IL1R2, by contrast, did not maintain the same coherent pattern across all assays. This convergence convinced the researchers that ARG1 stands out as a robust and reliable indicator of nanoplastic-induced placental toxicity, a biomarker candidate that could prove valuable both for future mechanistic studies and, potentially, for monitoring real-world exposure effects.

The functional implications go deeper than correlation. Because arginase 1 is a defining effector molecule of the M2 program, its suppression effectively disarms the anti-inflammatory arm of placental macrophages. In the co-culture experiments, the researchers demonstrated that nanoplastic exposure suppressed the M2 anti-inflammatory phenotype while promoting the M1 pro-inflammatory phenotype, and that this polarization shift was driven by the inhibition of ARG1 expression. In other words, the particles do not simply provoke a generic inflammatory reaction; they reprogram immune cell identity by switching off a master regulator of the tolerance-promoting state. The macrophages themselves become agents of placental injury, releasing inflammatory signals in tissue that depends on calm for its function.

This mechanism helps explain how an environmental exposure could translate into developmental risk. An inflamed placenta is an inefficient placenta. Pro-inflammatory macrophage polarization has been implicated in a range of pregnancy complications, including preeclampsia, fetal growth restriction, and abnormal trophoblast invasion, and prior work by the same group linked nanoplastic exposure to ferroptosis, an iron-dependent form of cell death, in placental tissue through epigenetic mechanisms. The new findings add an immunological layer to that picture: even before cells die, the microenvironment around them is being pushed into a state that undermines nutrient exchange, vascular remodeling, and maternal-fetal immune tolerance, all of which are essential for normal fetal growth.

The study also arrives amid a rapidly expanding body of evidence that plastic particles penetrate the most protected compartments of the human body. Researchers have quantified microplastics in human placental specimens using pyrolysis gas chromatography mass spectrometry, detected them in maternal blood and umbilical vein blood, and traced their accumulation from placenta to fetal organs in animal models. Particle size matters as well: smaller nanoplastics cross biological barriers more readily than microplastics, and previous studies have shown that different particle sizes can differentially regulate pro-inflammatory macrophage polarization. What distinguishes the new work is that it moves beyond documenting the presence of these particles and identifies a specific molecular lever, ARG1, through which they exert their effect on a critical organ.

The researchers emphasize that their findings highlight a new risk factor for fetal development, one that arises from the collision between global plastic pollution and the immunological choreography of pregnancy. While the experiments were conducted in mouse models and human cell lines, the conserved biology of macrophage polarization and placental immune regulation suggests the mechanism is plausibly relevant to human pregnancies, particularly given the documented presence of plastics in human placentas. As nanoplastic contamination of air, food, and water continues to rise, the study underscores that the most vulnerable window of human development may be quietly exposed to particles capable of reprogramming the immune cells charged with protecting it. Identifying ARG1 as a consistent molecular signature of that exposure provides researchers with a concrete target for biomarkers, interventions, and, ultimately, a better understanding of how the modern material world shapes the earliest chapters of life.

Subject of Research: Effects of gestational polystyrene nanoplastic exposure on placental function and macrophage polarization

Article Title: Gestational polystyrene nanoplastic exposure impairs placental function via ARG1-associated macrophage polarization imbalance

Article References: Yujiao, C., Yifan, L., Shanshan, L., Wei, W., Meng, Z., & Yousheng, Y. (2026). Gestational polystyrene nanoplastic exposure impairs placental function via ARG1-associated macrophage polarization imbalance. Journal of Nanoparticle Research, 28(9), Article 242. https://doi.org/10.1007/s11051-026-06764-1

Image Credits: AI Generated

DOI: 10.1007/s11051-026-06764-1

Keywords: polystyrene nanoplastics, placental toxicity, macrophage polarization, ARG1, pregnancy, placenta, inflammation, fetal development, nanotoxicology, trophpoblast, HTR8/SVneo, immune tolerance